2cureX AB Logo

2cureX AB

Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.

2CUREX | ST

Overview

Corporate Details

ISIN(s):
SE0010468124
LEI:
549300SFOL75WIYF2O80
Country:
Sweden
Address:
Box 159, 261 22 Landskrona

Description

2cureX AB is a company specializing in functional precision oncology, dedicated to improving cancer treatment outcomes. The company develops and commercializes the IndiTreat® test, a CE-marked in vitro diagnostic (IVD) tool that predicts individual patient response to cancer therapies. The IndiTreat® technology uses 3D tumoroids, or micro-tumors, grown from a patient's own biopsy. These tumoroids are then tested against various cancer drugs to identify the most effective treatment option before it is administered to the patient. This approach provides oncologists with personalized data to guide therapy selection, with an initial focus on patients with advanced cancers like metastatic colorectal cancer. By directly measuring drug sensitivity, 2cureX aims to provide a higher level of precision in personalized medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all 2cureX AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 2cureX AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 2cureX AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS
Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.